Department of Perioperative Services, Intensive Care Medicine and Pain Management, Turku University Hospital, Turku, Finland
Research and Development Unit, FinnHEMS Ltd, Vantaa, Finland.
BMJ Open. 2022 May 17;12(5):e059766. doi: 10.1136/bmjopen-2021-059766.
Prehospital critical care physicians regularly attend to patients with poor prognosis and may limit the advanced therapies. The aim of this study was to evaluate the accuracy of poor prognosis given by prehospital critical care clinicians.
Cohort study.
We performed a retrospective cohort study using the national helicopter emergency medical services (HEMS) quality database.
Patients classified by the HEMS clinician to have survived until hospital admission solely because of prehospital interventions but evaluated as having no long-term survival by prehospital clinician, were included.
The survival of the study patients was examined at 30 days, 1 year and 3 years.
Of 36 715 patients encountered by the HEMS during the study period, 2053 patients were classified as having no long-term survival and included. At 30 days, 713 (35%, 95% CI 33% to 37%) were still alive and 69 were lost to follow-up. Furthermore, at 1 year 524 (26%) and at 3 years 267 (13%) of the patients were still alive. The deceased patients received more often prehospital rapid sequence intubation and vasoactives, compared with patients alive at 30 days. Patients deceased at 30 days were older and had lower initial Glasgow Coma Scores. Otherwise, no clinically relevant difference was found in the prehospital vital parameters between the survivors and non-survivors.
The prognostication of long-term survival for critically ill patients by a prehospital critical care clinician seems to fulfil only moderately. A prognosis based on clinical judgement must be handled with a great degree of caution and decision on limitation of advanced care should be made cautiously.
院前重症监护医师经常治疗预后不良的患者,并可能限制使用高级治疗方法。本研究旨在评估院前重症监护临床医生预测预后不良的准确性。
队列研究。
我们使用国家直升机紧急医疗服务(HEMS)质量数据库进行了回顾性队列研究。
仅因院前干预而被 HEMS 临床医生评估为存活至入院但被院前临床医生评估为无长期存活的患者被纳入研究。
研究患者的生存率在 30 天、1 年和 3 年时进行了检查。
在研究期间,HEMS 共遇到 36715 名患者,其中 2053 名患者被归类为无长期存活并被纳入研究。在 30 天时,713 名(35%,95%CI 33%至 37%)患者仍然存活,69 名患者失访。此外,1 年后有 524 名(26%)和 3 年后有 267 名(13%)患者仍然存活。与 30 天存活的患者相比,死亡患者更频繁地接受院前快速序贯插管和血管活性药物治疗。30 天内死亡的患者年龄较大,初始格拉斯哥昏迷评分较低。除此之外,在院前生命体征方面,存活者与非存活者之间没有发现有临床意义的差异。
院前重症监护临床医生对危重症患者的长期生存预后预测似乎只是中等程度的准确。基于临床判断的预后必须非常谨慎地处理,并且应谨慎决定是否限制高级护理。